The rise of Viagra initially drove a period of growth for major pharmaceutical companies, nevertheless recent changes present a complicated scenario for shareholders. Off-patent alternatives are eating into profits, https://victorglrm057570.ttblogs.com/21108981/the-blue-pill-and-the-pharmaceutical-industry-a-risky-play